<code id='E524B3DC34'></code><style id='E524B3DC34'></style>
    • <acronym id='E524B3DC34'></acronym>
      <center id='E524B3DC34'><center id='E524B3DC34'><tfoot id='E524B3DC34'></tfoot></center><abbr id='E524B3DC34'><dir id='E524B3DC34'><tfoot id='E524B3DC34'></tfoot><noframes id='E524B3DC34'>

    • <optgroup id='E524B3DC34'><strike id='E524B3DC34'><sup id='E524B3DC34'></sup></strike><code id='E524B3DC34'></code></optgroup>
        1. <b id='E524B3DC34'><label id='E524B3DC34'><select id='E524B3DC34'><dt id='E524B3DC34'><span id='E524B3DC34'></span></dt></select></label></b><u id='E524B3DC34'></u>
          <i id='E524B3DC34'><strike id='E524B3DC34'><tt id='E524B3DC34'><pre id='E524B3DC34'></pre></tt></strike></i>

          hotspot

          hotspot

          author:entertainment    Page View:8341
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more
          Virtual Event: March of the Biosimilars
          Virtual Event: March of the Biosimilars

          Editor’snote:Arecordingoftheeventisembeddedbelow.SeveralbiosimilarversionsofHumira,whichforyearshasb

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          5 to watch: Tech startups trying to solve health care's staffing crisis

          AdobeThreeyearsafterthepandemicupendedthehealthcareworkforce,hospitalstaffingisstillatopconcernforho